Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Omega Fund Management, LLC
Form 13F · Q2 2026

Omega Fund Management, LLC

CIK 1637359Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$186M
Reported book value
10
Positions
12
Quarters on record
Top 50
Positions

Omega Fund Management, LLC — holdings

Top 10 positions of 10, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1BCAX Bicara Therapeutics Inc1.8M−23.8%$54M29.1%
2NUVB Nuvation Bio Inc8.1M+0.0%$46M24.7%
3KESTRA MED TECHNOLOGIES LTD Kestra Med Technologies Ltd1.0M+0.0%$26M14.0%
4BBOT Bridgebio Oncology Therapeut3.3M+0.0%$25M13.5%
5BBNX Beta Bionics Inc1.3M+0.0%$21M11.1%
6ALMS Alumis Inc241,255+0.0%$7M3.7%
7SANA Sana Biotechnology Inc843,750+0.0%$3M1.6%
8IMA Imagenebio Inc455,361+0.0%$3M1.4%
9ENGENE HOLDINGS INC Engene Holdings Inc876,357+0.0%$2M0.8%
10ODTX Odyssey Therapeutics Inc2,893—$54,1280.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.